Management of massive diffuse alveolar hemorrhage in a child with systemic lupus erythematosus

Dai Kimura1, Samir Shah2, Mario Briceno-Medina3

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Le Bonheur Children's Hospital/University of Tennessee Health Science Center, 50 N. Dunlap St, TN Memphis, 38103 USA.

Insights

Diffuse alveolar hemorrhage (DAH) in systemic lupus erythematosus (SLE) is rare and dangerous. This case shows successful management of severe DAH in a young SLE patient using ECMO, surgery, and intensive medical therapy.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Systemic lupus erythematosus (SLE) can manifest with severe pulmonary complications.
  • Diffuse alveolar hemorrhage (DAH) is a rare but life-threatening SLE manifestation.

Observation:

  • A 14-year-old female with SLE presented with hypoxia and shock.
  • The patient experienced severe alveolar hemorrhage.

Findings:

  • Successful management involved extracorporeal membrane oxygenation (ECMO).
  • Emergent pulmonary lobectomy was performed.
  • Treatment included high-dose methylprednisolone, cyclophosphamide, IV immunoglobulin, and plasmapheresis.

Implications:

  • This case highlights a multidisciplinary approach for managing severe SLE-related DAH.
  • Aggressive treatment strategies, including ECMO and surgery, can be life-saving.
  • Early recognition and intervention are crucial for favorable outcomes in SLE-DAH.